A detailed history of Cetera Investment Advisers transactions in Cor Medix Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 19,624 shares of CRMD stock, worth $165,234. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,624
Previous 14,902 31.69%
Holding current value
$165,234
Previous $64,000 146.88%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.64 - $8.23 $17,188 - $38,862
4,722 Added 31.69%
19,624 $158,000
Q2 2024

Aug 22, 2024

BUY
$4.08 - $6.39 $11,220 - $17,572
2,750 Added 22.63%
14,902 $64,000
Q1 2024

May 24, 2024

BUY
$2.94 - $4.24 $35,726 - $51,524
12,152 New
12,152 $51,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $347M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.